Tissue Engineering
@TissueEngin
Followers
2K
Following
564
Media
673
Statuses
1K
The preeminent biomedical journal covering all aspects of tissue growth and regeneration
Joined May 2013
CALL FOR PAPERS: Biomaterials and Cell Strategies for Immunoengineering! Submission Deadline: May 31, 2026 Read more here:
0
0
1
AI meets dentistry: new review explores how artificial neural networks (ANNs) could support tissue-regeneration research in dental care, offering decision-support tools for complex modeling and personalized outcomes! Read more here: https://t.co/nvk4xJ0B7o
0
0
1
This new article shows that using poly(vinyl alcohol) (PVA) to encapsulate liver cell spheroids significantly boosts cell viability, metabolic function and in-vivo performance in mice! Read more here: https://t.co/ZWvYngggjd
0
0
0
Don't forget to check out the most recent edition of Tissue Engineering Part B Reviews now online with free access! Read more here: https://t.co/Il8JuwkJEv
0
1
2
CALL FOR PAPERS: Don't forget to submit your manuscripts on Cancer & Regenerative Medicine! Deadline: December 1, 2025 Read more here:
0
0
1
Check out the most recent edition of Tissue Engineering Part A, now online! Read more here: https://t.co/WRCKkgDItg
0
0
2
Check out this recent review article on extracellular matrix alterations and mechanisms via mitogen-activated protein kinase/matrix metalloproteinase, transforming growth factor-β pathways, and glycosaminoglycan metabolism in photoaging! Read more here: https://t.co/RcWvtZkTIq
0
0
1
Read this recent review article on the analysis of #3DPrinting strategies for meniscus/articular disc repair and regeneration! Read more here: https://t.co/4zNCdD9web
0
1
2
Check out this recently published review on the regenerative potential of neural stem/progenitor cells for bone repair! Read more here: https://t.co/oRoo2w8du8
0
1
2
This study from @KingsCollegeLon shows that fibronectin stimulates human vascular smooth muscle cells to secrete small extracellular vesicles by activating the β1 integrin/FAK/Src pathway and Arp2/3-dependent branching of the actin cytoskeleton. @eLife | https://t.co/ld8Lky9ECF
0
4
10
Interested in publishing in Tissue Engineering? Check out the page for authors for submission guidelines: https://t.co/SiHqqUR4Vb
@LiebertPub
0
0
2
Early registration deadline for @TERMISAM conference in Detroit, MI extended to October 20th! For more details on conference registration, click here: https://t.co/rcA6Xepxxt
@LiebertPub
0
0
1
DEADLINE APPROACHING: Call for papers on mechanobiology in tissue engineering! Manuscripts must be submitted by October 1, 2025 (TOMORROW!) Submit your manuscripts here: https://t.co/UegOXRbX5E
@LiebertPub
0
0
0
🧫 Researchers optimize a method for complete decellularization of rat esophagus and to solubilize the decellularized extracellular matrix proteins to evaluate in vitro properties for scaffold fabrication. 🥼 https://t.co/mm5ZDQS9k9
0
3
6
Don't forget to book your room at the HQ hotel for #TERMISAM2025, Detroit Marriott at the Renaissance Center. Reserve your room by the hotel cutoff date on October 27 to guarantee the best rate possible! https://t.co/Y9RtLM6hJV
0
1
0
CALL FOR PAPERS: Submit your manuscripts on biomaterials and cell strategies for immunoengineering! Deadline for submission is May 31, 2026. For more information, click here:
0
0
2
CALL FOR PAPERS: About two months left to submit your manuscripts on cancer & regenerative medicine! Deadline for submission is December 1, 2025. For more information, click here:
0
1
1
CALL FOR PAPERS: One week left to submit your manuscript on mechanobiology in tissue engineering! Deadline for submission is October 1, 2025. For more information, click here:
0
1
0
In this study, scientists with Dr. Canan Nebigil developed human 3D #BreastCancer spheroids. At higher doxorubicin concentrations, #chemoresistance was mitigated independently of HIF-1α and promoted apoptosis and ROS accumulation. 🔓 https://t.co/mdEYlHD73s
0
2
1
Check out this recent article on osteoclast incorporation in an in vitro 3D model of endochondral ossification! Read more here: https://t.co/c8jZhfouaR
0
1
0